Healthcare Claims Processing Platforms and Medical Financial Control

Introduction

Healthcare claims processing platforms are digital systems used by insurers, hospitals, third-party administrators (TPAs), health-tech companies, and government programmes to receive, validate, price, adjudicate, audit, and pay medical claims. Increasingly, these systems incorporate artificial intelligence, automated fraud detection, predictive analytics, electronic health records, provider databases, coding engines, and algorithmic decision-making.

Medical financial control refers to the ability of an insurer, platform operator, hospital network, administrator, or other intermediary to influence the financial flow of healthcare by controlling reimbursement rules, claim approvals, coding, payment timing, network access, risk scoring, prior authorisation, and information necessary to obtain payment.

The competition-law concern arises when a claims-processing platform moves beyond being a neutral technological intermediary and becomes an economic bottleneck through which healthcare providers, insurers, patients, and competing platforms must operate.

The central legal question is therefore:

When does control over healthcare claims infrastructure become control over the competitive conditions of healthcare markets?

1. Meaning and Structure of Healthcare Claims Processing Platforms

A claims-processing platform may perform several functions:

1. Claim submission
2. Patient and policy verification
3. Medical coding validation
4. Eligibility checking
5. Fraud and abuse detection
6. Prior-authorisation assessment
7. Reimbursement calculation
8. Network-provider validation
9. Payment routing
10. Appeals management
11. Data analytics
12. Provider performance scoring
13. Risk adjustment
14. Automated denial decisions
15. Audit and compliance monitoring.

A simplified structure is:

Patient → Hospital/Doctor → Claims Platform → Insurer/TPA → Payment System

The platform may therefore sit between the party providing healthcare and the party financing healthcare.

Where the same company controls multiple layers, it may obtain substantial vertical and cross-market power.

2. Medical Financial Control

Medical financial control can arise where an organisation controls:

• reimbursement rates;
• claims-processing standards;
• medical coding;
• provider eligibility;
• claim-denial algorithms;
• prior authorisation;
• payment schedules;
• access to insurer networks;
• provider rankings;
• fraud-risk scores;
• medical necessity determinations;
• claims data;
• patient financial information;
• interoperability standards.

The most important competition concern is not simply that the platform processes claims.

The concern is that control of claims processing can become control of access to revenue.

For example, if hospitals depend upon one platform to obtain reimbursement, exclusion from that platform may effectively deprive them of access to a major payer or patient population.

3. Claims Platforms as Potential Essential Infrastructure

A claims platform can acquire characteristics of an essential input where:

• a large proportion of healthcare claims pass through it;
• competing platforms cannot realistically reproduce its network;
• insurers require providers to use it;
• providers require access to insurers through it;
• interoperability is limited;
• switching costs are high;
• the platform possesses unique claims data;
• the platform controls technical certification;
• the platform integrates claims, payment, and provider-network information.

The resulting structure can resemble a bottleneck:

Healthcare Provider → Platform → Insurer → Payment

If the platform becomes indispensable, denial or discriminatory access can have competitive consequences.

4. Relevant Competition Markets

Several relevant markets may have to be distinguished.

A. Claims-processing services

The relevant market may include software and services used to:

• submit claims;
• adjudicate claims;
• validate medical information;
• detect fraud;
• calculate reimbursement.

B. Healthcare payment infrastructure

A broader market may encompass:

• payment routing;
• reimbursement systems;
• electronic funds transfer;
• claims clearinghouses.

C. Provider-network services

A platform may simultaneously operate a provider network.

D. Health-data analytics

Claims data can support:

• risk scoring;
• actuarial analysis;
• provider profiling;
• pricing;
• fraud detection.

E. Insurance administration

A platform may also provide:

• underwriting;
• claims administration;
• prior authorisation;
• benefits management.

This creates possibilities for leveraging power from one market into another.

5. Data as a Source of Financial Control

Claims-processing systems generate extremely valuable information, including:

• diagnosis codes;
• treatment history;
• procedure costs;
• reimbursement rates;
• provider behaviour;
• patient utilisation;
• denial rates;
• prescription information;
• hospital performance;
• insurer payment patterns.

A dominant platform can therefore possess a significant informational advantage.

Competitors may face a data-access disadvantage.

The competitive concern becomes particularly serious when:

The platform uses data obtained from customers to compete against those same customers.

For example, a claims platform could theoretically observe the claims patterns of hospitals and then offer competing healthcare-management services using insights unavailable to those hospitals.

6. Network Effects

Claims platforms exhibit significant network effects.

More insurers using the platform may attract more hospitals.

More hospitals may make the platform more valuable to insurers.

More transactions produce more data.

More data can improve:

• fraud detection;
• pricing;
• automated adjudication;
• provider scoring;
• prediction;
• claims accuracy.

This creates a potential feedback loop:

More users → More claims → More data → Better algorithms → More users → Greater market power

Such a feedback loop can produce substantial barriers to entry.

7. Switching Costs

Healthcare claims infrastructure is particularly susceptible to switching costs because healthcare providers and insurers must integrate:

• billing systems;
• electronic health records;
• coding systems;
• APIs;
• payer identifiers;
• reimbursement rules;
• compliance systems;
• patient databases.

Changing platforms may require:

• technical migration;
• employee retraining;
• contractual renegotiation;
• data conversion;
• regulatory validation;
• testing;
• cybersecurity assessment.

Consequently, even where nominally competing platforms exist, customers may be effectively locked in.

8. Foreclosure Risks

A dominant claims platform could potentially engage in several exclusionary practices.

8.1 Discriminatory access

The platform may provide competitors with inferior:

• APIs;
• processing speeds;
• data fields;
• technical access;
• payment interfaces.

8.2 Self-preferencing

If the platform provides both claims processing and healthcare-management services, it might favour its own downstream products.

8.3 Bundling

Claims processing may be tied to:

• insurance products;
• provider-network participation;
• fraud analytics;
• payment services.

8.4 Exclusivity

Providers or insurers could be required to use the platform exclusively.

8.5 Data leveraging

The platform may use claims data to compete in downstream markets.

8.6 Excessive switching costs

Technical or contractual restrictions may make migration unnecessarily difficult.

9. Algorithmic Medical Financial Control

Artificial intelligence can increase the platform's financial influence.

An automated claims system may determine:

• whether a treatment is medically necessary;
• whether a claim appears fraudulent;
• whether a procedure is reimbursable;
• whether additional documentation is required;
• whether prior authorisation is necessary;
• whether a provider is high risk.

If the algorithm becomes sufficiently influential, a private technology system can effectively determine who gets paid and how much.

This raises competition and governance concerns because the platform may exercise economic power without formally being the insurer.

10. Automated Denials and Market Power

Automated claim-denial systems create a particularly important problem.

Suppose a dominant claims processor uses an algorithm that systematically increases denial rates for certain providers.

Even if the platform does not directly compete with those providers, it may affect their:

• revenue;
• liquidity;
• ability to serve patients;
• bargaining power;
• network participation.

If the platform owns or controls competing healthcare providers, this creates a possible vertical foreclosure problem.

11. Medical Financial Control and Consumer Welfare

The effects may ultimately reach patients.

A platform can influence:

• treatment affordability;
• provider availability;
• reimbursement;
• insurance premiums;
• claim delays;
• out-of-pocket costs.

Thus, competition analysis should not examine only the price paid for claims-processing software.

It should also consider:

• quality;
• access;
• innovation;
• privacy;
• reliability;
• transparency;
• healthcare choice.

In digital healthcare markets, non-price effects may be particularly important.

12. Important Case Laws

The following cases provide useful legal principles for analysing healthcare claims-processing platforms and medical financial control.

1. United Brands v Commission

Case: United Brands Company v Commission, Case 27/76 (CJEU)

The Court recognised that a dominant undertaking has a special responsibility not to impair genuine competition.

Relevance

A dominant healthcare claims platform could therefore face heightened scrutiny if it uses control over an indispensable processing infrastructure to disadvantage healthcare providers or competing platforms.

The case is especially useful for the proposition that dominance itself is not unlawful; abusive exploitation of dominance is.

13. Bronner v Mediaprint

Case: Oscar Bronner GmbH & Co KG v Mediaprint, Case C-7/97 (CJEU)

This case established an important framework for refusal-to-supply and essential-facility arguments.

The Court required stringent conditions before imposing a duty on a dominant undertaking to provide access to infrastructure.

Relevance

A healthcare claims platform cannot automatically be required to provide access merely because competitors find its infrastructure useful.

The claimant would need to demonstrate, among other things, that the infrastructure is genuinely indispensable and that duplication is not realistically possible.

This is particularly important where a claims-processing platform has become the primary gateway to healthcare reimbursement.

14. IMS Health v Commission

Case: IMS Health GmbH & Co OHG v NDC Health GmbH & Co KG, Case C-418/01 (CJEU)

The case concerned access to a highly valuable data structure and intellectual-property-related infrastructure.

The Court developed stringent conditions concerning compulsory access.

Relevance

Healthcare claims databases may become competitively significant infrastructure.

Where a platform possesses unique claims data or data structures that competitors cannot reasonably reproduce, data access and interoperability can become competition-law issues.

The case is therefore highly relevant to claims-data monopolisation.

15. Microsoft v Commission

Case: Microsoft Corp v Commission, Case T-201/04

The General Court upheld significant findings concerning Microsoft's refusal to provide interoperability information to competitors.

Relevance

The case is highly relevant to healthcare claims-processing ecosystems.

A dominant claims platform could potentially restrict:

• API access;
• interoperability;
• technical specifications;
• data portability;
• integration with competing claims systems.

If such restrictions substantially impair competition, Microsoft provides a useful analytical framework.

16. Google Shopping

Case: Google and Alphabet v Commission, Case T-612/17

The General Court upheld the Commission's finding concerning Google's preferential treatment of its own comparison-shopping service.

Relevance

The principle of self-preferencing can become relevant where a claims platform operates competing downstream services.

For example:

Claims-processing platform + provider-management platform

could create incentives to rank or process the platform's own downstream healthcare products more favourably.

The competition issue would be whether the platform's conduct departs from competition on the merits and produces exclusionary effects.

17. Slovak Telekom v Commission

Case: Slovak Telekom a.s. v Commission, Joined Cases C-165/19 P and C-166/19 P

The case concerned exclusionary conduct involving access to telecommunications infrastructure.

Relevance

Healthcare claims platforms can similarly function as vertically integrated infrastructures.

A platform controlling access to claims processing could potentially disadvantage downstream competitors through:

• discriminatory access;
• inferior interfaces;
• pricing discrimination;
• technical restrictions;
• strategic bundling.

The case demonstrates how infrastructure control can have downstream competitive consequences.

18. Intel v Commission

Case: Intel Corp v Commission, Case C-413/14 P

The CJEU emphasised that, for certain exclusivity practices, competition authorities must examine their ability to foreclose equally efficient competitors where that analysis is relevant.

Relevance

If a healthcare claims platform imposes exclusivity arrangements on hospitals or insurers, authorities should examine:

• duration;
• market coverage;
• platform dominance;
• switching costs;
• foreclosure capability;
• efficiencies.

This is particularly important where hospitals cannot realistically maintain multiple claims-processing systems.

19. Aspen v Commission

Case: Case T-321/05, AstraZeneca/Commission is distinct from Aspen; a useful EU example is the Commission's Aspen Pharma enforcement concerning excessive pricing and supply withdrawal.

Relevance

Healthcare markets have distinctive characteristics because interruption of supply or access can affect patients directly.

Where control over a healthcare infrastructure allows an undertaking to impose exploitative financial conditions, competition authorities may consider both economic and healthcare-market effects.

The broader lesson is that competition law can take account of the special characteristics of healthcare markets.

20. United States: Mylan v Warner Chilcott

Case: Mylan Pharmaceuticals Inc. v Warner Chilcott Public Ltd. Co., 838 F.3d 421 (3d Cir. 2016)

The case concerned competition in pharmaceutical markets and exclusionary conduct.

Relevance

Although not a claims-processing-platform case, it illustrates how conduct in healthcare markets can be analysed through conventional antitrust principles where exclusionary strategies affect competitors and market access.

It is useful by analogy when examining platform strategies that restrict rival healthcare providers or services.

21. United States: FTC v Surescripts

Case: FTC v Surescripts, LLC

The Federal Trade Commission challenged alleged exclusionary practices involving electronic prescribing infrastructure.

Relevance

This is particularly significant for healthcare technology platforms because it demonstrates how digital healthcare infrastructure itself can become an antitrust concern.

The case illustrates the importance of examining:

• exclusivity;
• interoperability;
• network effects;
• switching costs;
• healthcare-information infrastructure.

It provides a close conceptual analogy to claims-processing platforms.

22. Competition-Law Theory Applied to Claims Platforms

A useful analytical framework is:

Stage 1 — Identify the platform

Determine whether the undertaking is merely a software vendor or whether it controls an essential economic gateway.

Stage 2 — Define the market

Possible markets include:

• claims processing;
• claims clearing;
• healthcare payment;
• provider-network management;
• healthcare data analytics.

Stage 3 — Assess market power

Consider:

• market share;
• network effects;
• switching costs;
• data advantages;
• interoperability;
• contractual exclusivity;
• barriers to entry.

Stage 4 — Identify conduct

Examine:

• refusal to deal;
• discriminatory access;
• self-preferencing;
• tying;
• bundling;
• exclusivity;
• data leveraging;
• predatory pricing;
• excessive pricing.

Stage 5 — Assess effects

Consider:

• foreclosure;
• increased costs;
• reduced provider choice;
• reduced innovation;
• delayed reimbursement;
• degraded quality;
• higher insurance costs.

23. Medical Financial Control as a Two-Sided Market

Many claims platforms operate as two-sided or multi-sided markets.

They connect:

Insurers ↔ Claims Platform ↔ Healthcare Providers

and sometimes:

Patients ↔ Providers ↔ Insurers ↔ Payment Networks

The platform therefore has incentives to optimise the entire ecosystem rather than merely sell software.

This can make traditional single-market analysis inadequate.

A conduct that benefits one side may harm another.

For example:

Lower claims-processing prices for insurers could be financed through higher provider fees.

Consequently, competition authorities should consider cross-market effects.

24. Financial Dependency and Bargaining Power

A hospital may become financially dependent on a claims platform if:

• most reimbursements are processed through it;
• alternative processors are unavailable;
• switching takes months;
• payment information is platform-controlled;
• the platform determines claims priority;
• insurers contract exclusively with it.

This can produce economic dependency even without formal monopoly status.

The platform's bargaining position can consequently become disproportionate to its technological function.

25. Interoperability as a Competition Remedy

One potential remedy is mandatory interoperability.

Authorities could require:

• open APIs;
• standardised claims formats;
• data portability;
• transparent technical specifications;
• reasonable access terms;
• non-discriminatory interfaces.

Interoperability can reduce:

• switching costs;
• network effects;
• data advantages;
• entry barriers.

However, mandatory access must be carefully designed because excessive regulation may undermine cybersecurity, privacy, and legitimate intellectual-property protection.

26. Data Portability

Data portability can reduce platform lock-in.

A provider could move:

• claims history;
• coding information;
• payment records;
• patient-authorisation data;
• transaction history.

from one platform to another.

Competition policy can therefore interact with data-protection and digital-market regulation.

27. Algorithmic Transparency

Where algorithms determine claim outcomes, competition authorities and regulators may need to examine:

• model accuracy;
• discriminatory error rates;
• denial thresholds;
• auditability;
• human review;
• explainability;
• data provenance.

Transparency is particularly important where the same platform controls both the algorithm and the underlying claims data.

28. Conflicts of Interest

The most serious structural concern arises where the platform simultaneously acts as:

1. claims processor;
2. insurer;
3. provider-network operator;
4. healthcare provider;
5. data analytics company.

This creates incentives to use infrastructure power to favour affiliated businesses.

For example:

Claims data → algorithm → provider ranking → network allocation → reimbursement

may become one integrated chain of economic control.

29. Potential Abuses

Potential abuses include:

30. Key Legal Tests

A competition authority would generally ask:

1. Is the platform dominant?

2. Is the platform infrastructure indispensable?

3. Can competitors reasonably reproduce it?

4. Does the platform discriminate between users?

5. Does it favour affiliated businesses?

6. Does it exploit proprietary data?

7. Are contractual restrictions exclusionary?

8. Are there legitimate efficiencies?

9. Can less restrictive alternatives achieve those efficiencies?

10. What is the actual or likely effect on competition?

31. Regulatory Remedies

Possible remedies include:

Structural remedies

• separation of claims processing and insurance;
• divestiture;
• functional separation.

Behavioural remedies

• non-discriminatory access;
• interoperability;
• fair pricing;
• transparency;
• prohibition of exclusivity.

Data remedies

• portability;
• data-access obligations;
• restrictions on secondary use.

Algorithmic remedies

• independent audits;
• human review;
• explainability;
• audit trails;
• model-risk controls.

32. Six Major Competition-Law Principles Emerging from the Case Law

The cases collectively support six important propositions:

1. Dominance itself is not unlawful, but dominant firms have special responsibilities.
2. Infrastructure control can create downstream foreclosure risks.
3. Indispensability matters in refusal-to-deal cases.
4. Interoperability restrictions can have competition effects.
5. Self-preferencing may constitute abusive leveraging in appropriate circumstances.
6. Exclusivity must be evaluated according to its actual foreclosure capability and effects.

Conclusion

Healthcare claims-processing platforms are increasingly more than administrative software. Where they aggregate claims data, determine reimbursement, control interoperability, manage provider access, operate payment infrastructure, and employ algorithmic decision-making, they can become critical economic infrastructure within healthcare markets.

The principal competition-law danger is the transformation of technological intermediation into medical financial control:

Control over claims infrastructure → control over information → control over reimbursement → control over provider incentives → potential control over healthcare competition.